On this episode of the JVRD Author’s Forum podcast, Dr. Albert Li of Vitreoretinal Consultants of New York discusses “Multiple Successive Branch Retinal Artery Occlusions in a Patient with Antiphospholipid Syndrome Despite Anticoagulation,” published in the July/August 2025 issue of the Journal of VitreoRetinal Diseases.

Host Dr. Timothy Murray and Dr. Li review a striking case in which a patient with triple-negative antiphospholipid syndrome experienced multiple branch retinal artery occlusions despite anticoagulation and later died from systemic complications. Hear how this case underscores the limits of current therapies, the value of fluorescein angiography and other imaging for diagnosis, and the importance of urgent, multidisciplinary evaluation of retinal arterial occlusions as possible harbingers of systemic vascular disease.

For more information, visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.

On this episode of the JVRD Author’s Forum podcast, Dr. Lucia Sobrin of the Massachusetts Eye and Ear Infirmary at Harvard Medical School discusses “Clinical Characteristics, Outcomes, and Complications Associated with Delayed Diagnosis of Intraocular Foreign Bodies,” published in the July/August 2025 issue of the Journal of VitreoRetinal Diseases.

Host Dr. Timothy Murray and Dr. Sobrin review her team’s findings from a large case series of patients with delayed intraocular foreign body diagnosis. Hear how careful history-taking, anterior and posterior segment exams, gonioscopy, and adjunctive imaging can uncover missed foreign bodies, why many of these patients still had relatively good vision, and what surgical considerations—including vitrectomy, lens management, and intravitreal antibiotics—can improve outcomes.

For more information, visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.

On this episode of the JVRD Author’s Forum podcast, Dr. Marta Stevanovic of the Massachusetts Eye and Ear Infirmary at Harvard Medical School discusses “Intraocular Inflammation, Safety Events, and Outcomes After Intravitreal Injection of Ranibizumab, Aflibercept, Brolucizumab, Abicipar Pegol, and Faricimab for nAMD,” published in the July/August 2025 issue of JVRD.

Host Dr. Timothy Murray and Dr. Stevanovic review her team’s network meta-analysis of phase 3 clinical trial data comparing anti-VEGF agents used for neovascular AMD. Hear what the study reveals about the relative risk of intraocular inflammation, endophthalmitis, vasculitis, and other events, why real-world experience still matters, and how these findings can guide clinicians in their use of anti-VEGF therapies.

For more information, visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.

On this episode of the JVRD Author’s Forum podcast, Dr. Timothy Murray, Editor-in-Chief of JVRD, speaks with co-authors Dr. Aleksandra V. Rachitskaya of the Cole Eye Institute at the Cleveland Clinic and Dr. Yoshihiro Yonekawa of Wills Eye Hospital and Mid Atlantic Retina about their article “Peer Review Essentials: Reviewing Manuscripts for the Journal of Vitreoretinal Diseases," published in the July/August issue of JVRD.

Together, they highlight why peer review is foundational to advancing retinal research and clinical care, how structured and systematic reviews strengthen manuscripts, and what makes an effective reviewer. Hear practical guidance on accepting review invitations, providing constructive feedback, and avoiding common pitfalls such as overstating conclusions. The discussion also underscores how peer review not only elevates the journal but also helps reviewers grow as writers and researchers.

To learn more about peer review and JVRD, access the Peer Review Essentials Webinar (ASRS Members Only).

For more information, visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.

On this episode of the JVRD Author's Forum podcast, Dr. Nikhil Batra of the Dartmouth School of Medicine discusses "Belzutifan as the Primary Treatment of Bilateral Juxtapapillary Retinal Hemangioblastoma in a Patient With von Hippel–Lindau Disease," published in the May/June 2025 issue of JVRD.

Host Dr. Timothy Murray and Dr. Batra discuss how belzutifan, a HIF-2α inhibitor, was used off-label to successfully treat bilateral optic nerve hemangioblastomas in a patient with Von Hippel-Lindau Disease, resulting in significant tumor regression and visual improvement. Hear how this targeted therapy may represent a promising new direction in managing complex retinal tumors that are difficult to treat with traditional approaches.

On this episode of the JVRD Author's Forum podcast, Dr. David Eichenbaum of Retina Vitreous Associates of Florida discusses "Biosimilar Ranibizumab (RaniEyes) Safety and Efficacy in the Real World: BRESER Study," published in the May/June 2025 issue of JVRD.

Host Dr. Timothy Murray and Dr. Eichenbaum talk about how biosimilars are developed and approved, and why real-world data is essential for evaluating their safety and effectiveness on a large scale. Learn why cost, access, and post-market surveillance are important factors in the growing role of biosimilars in retina care.

For more information, visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.

On this episode of the JVRD Author’s Forum podcast, Dr. Stefanie Schuman of the Duke Eye Center discusses 'Diabetic Retinopathy Disease Burden in Patients With Lower Household Incomes vs Higher Household Incomes,' published in the May/June 2025 issue of JVRD.

Host Dr. Timothy Murray and Dr. Schuman discuss her study examining how household income, estimated by ZIP code, impacts the disease burden of diabetic retinopathy at presentation. Hear how socioeconomic barriers like access to care, diabetes control, and follow-up challenges contribute to worse outcomes, and why addressing social determinants of health is key to improving equity in retinal care.

For more information, visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.

In this episode of the JVRD Authors Forum, host Dr. Timothy Murray speaks with Dr. Alan Franklin of the Diagnostic and Medical Clinic in Mobile, Alabama, about his study exploring the use of postoperative methotrexate to reduce reoperation rates and improve outcomes in patients with complex retinal detachments, advanced diabetic retinopathy, and ocular trauma. Hear how real-world results sparked this investigation and why methotrexate may be a game-changer in managing proliferative vitreoretinopathy and retinal inflammation.

For more information, visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.